seed
Stage
4
Investors
About
Xylo develops targeted neurotherapeutics that enhance neuroplasticity to restore brain function in neurological and psychiatric disorders using neuroscience and computational drug discovery.
Explore Xylo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.